echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Chemicals Industry > China Chemical > The pharmaceutical industry has set off an AI pharmacy fever, and pharmaceutical companies may see new opportunities

    The pharmaceutical industry has set off an AI pharmacy fever, and pharmaceutical companies may see new opportunities

    • Last Update: 2021-12-31
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [ Focus on Chemical Machinery and Equipment Network ] In recent years, in the context of the continuous growth of the global biomedicine scale and the exponential increase in the cost and time of research and development of a new drug, a large number of pharmaceutical companies have begun to gather together to deploy AI pharmaceuticals
    .
    For example, Roche and Genentech signed a broad cooperation agreement with Recursion, which uses artificial intelligence to drive drug discovery
    .

    Chemical machinery and equipment network hotspots pay attention to chemical machinery and equipment
    In addition, Jingxin Pharmaceutical and AI drug research and development company Jingtai Technology have also reached a project cooperation to jointly promote the research and development of small molecule antidepressant drugs
    .
    It is reported that in this cooperation, the two parties will focus on the research and development of innovative small-molecule antidepressant drugs with independent intellectual property rights, and apply AI technology to the design, optimization and verification of preclinical drug candidates for this project, and accelerate the development of drugs that are urgently needed by patients with depression
    .

     

    For the reason why AI pharmaceuticals are so hot, the industry said that this is mainly because it can solve the pain points of artificial pharmaceuticals to a certain extent, including improving the success rate of new drug research and development, reducing related costs and time in the pharmaceutical process, and bringing rich returns to enterprises And so on
    .
    You should know that traditional biopharmaceutical companies have always had pain points such as long R&D cycles, high failure rates, and high costs when conducting new drug R&D
    .

     

      Therefore, the industry is generally optimistic about the application prospects of artificial intelligence in the field of biomedicine
    .
    With the steadily expanding use of AI in the biopharmaceutical industry from early drug discovery to prescription treatment options, the industry predicts that by 2024, its market capacity will reach one billion U.
    S.
    dollars (including AI-based medical imaging, diagnosis, and personal AI assistant, drug discovery and genomics)
    .

     

      It is worth noting that as the scope of AI applications becomes wider and wider, AI is expected to play an increasingly powerful role in the medical field
    .
    Especially under the background that pharmaceutical companies and investors are highly optimistic about AI+pharmaceuticals and overweight the layout, the pharmaceutical industry may accelerate the ushering in a new era of AI-driven pharmaceuticals
    .
    In addition to the pharmaceutical field, as the domestic digitization process accelerates, the industry expects that the integration of AI and the pharmaceutical equipment industry will further accelerate, and it will play an important role in equipment innovation and management
    .

     
    Pharmaceutical equipment
      In fact, many pharmaceutical equipment companies have begun to join the exploration of AI+ pharmaceutical equipment and have carried out active practices
    .
    For example, many companies are focusing their firepower to promote the "robots instead of labor" production model, using Internet technology, Internet of Things technology, automated logistics systems and other technologies to break traditional technological processes
    .

     

      Among them, some pharmaceutical equipment companies have upgraded the spray camera recognition and early warning system of their products through the above technologies, and are equipped with image and video recognition technology.
    On the basis of reducing user costs, it also improves the product qualification rate and production safety
    .
    There Compressor manufacturers are using smart digital sensors and the traceability system, visual inspection, automatic monitoring system, pharmaceutical companies help improve the production quality control system, and a 30% increase in labor productivity
    .

     
    compressor
      On the whole, AI is gradually becoming a new breakthrough to promote the high-quality development of the pharmaceutical equipment industry, and it continues to have an impact on technological innovation, management, and systems
    .
    In the future, as AI continues to promote technological transformation, optimization and upgrading of the pharmaceutical equipment industry, and achieve fundamental changes in the pharmaceutical equipment industry model and corporate form, the industry expects it will further accelerate the transformation and upgrading of the pharmaceutical equipment industry
    .

     

      Original title: The pharmaceutical industry has set off an AI pharmacy fever, and pharmaceutical companies may have new opportunities
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.